Stock Chart

ZTS

$83.82 +1.04%
Score: 38.0 AVOID NEW MONEY
LEAPs: SELL $85
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $85
Premium: $14.44
Expiry: Dec 17, 2027
Target: $82
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.69x (vs SPY: 0.9x | vs QQQ: 0.9x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Nov 13, 2026
Rising Channel weak / forming — below our quality gate quality 45/100
A Rising Channel is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Lower rail breaks first 80% of the time (n=1,744) — a trend-exit tell, not a crash call
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About ZTS - ZOETIS INC.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on), and nearly 65% from companion animal (dogs, horses, cats) products. Its us business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

Key Statistics

Market Cap $34B
P/E Ratio 14.11
Dividend Yield 0.03%

This ZTS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track ZTS's price movements with trendlines, gamma walls, and key support/resistance levels.